17 Apr SAHPRA Statement – Update on Sisonke Phase 3B Implementation Study

Posted at 11:26h in News & Updates, Press Releases

17 April 2021 SAHPRA has engaged with the Sisonke Phase 3B Implementation Study team and Janssen Pharmaceutica. The focus of the engagement was on the safety data reported from the Sisonke study, following administration of the COVID-19 vaccine Janssen, as well as the adverse events reported...

Guido Hofmann via Unsplash

13 Apr Statement by the Minister of Health, Dr Zwelini Mkhize, on the FDA’s Temporary Suspension of Johnson and Johnson vaccine rollout in the United States

Posted at 20:39h in News & Updates, Press Releases

13 April 2021 We have noted the decision taken by the Food and Drug Administration in the United States of America to advise the temporary suspension of the Johnson and Johnson vaccine rollout in the US. This has occurred to due reports of 6 females who developed...

Johnson and Johnson Tag

17 Apr SAHPRA Statement – Update on Sisonke Phase 3B Implementation Study

13 Apr Statement by the Minister of Health, Dr Zwelini Mkhize, on the FDA’s Temporary Suspension of Johnson and Johnson vaccine rollout in the United States

Contact us

Quick Menu

I want to..

Subscribe

Follow us |